KSPHF (Kissei Pharmaceutical Co) Moat Score: 5/10 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KSPHF Kissei Pharmaceutical Co Ltd KSPHF
79 GF Score
Price $25.77
GF Value $31.34
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co Moat Score?

Kissei Pharmaceutical Co KSPHF -4.45% 79 Moat Score is 5 as of Aug. 04, 2026. GuruFocus rates KSPHF with a GF Score™ of 79/100 and a GF Value™ of $31.34. The stock has 1 warning sign investors should review. Among 1,029 Drug Manufacturers companies, Kissei Pharmaceutical Co ranks better than 94.66% on this metric.

Kissei Pharmaceutical Co has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Kissei Pharmaceutical Co has Narrow Moat: Kissei Pharmaceutical Co Ltd has a solid narrow moat due to its valuable patents and R&D capabilities in the pharmaceutical industry. It benefits from some pricing power and regulatory barriers, but intense competition and limited market share prevent a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Kissei Pharmaceutical Co might have Narrow Moat - Solid narrow moat.

Kissei Pharmaceutical Co  (OTCPK:KSPHF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Kissei Pharmaceutical Co Moat Score Related Terms

KSPHF vs ZTS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kissei Pharmaceutical Co Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Moat Score falls into.


KSPHF
79GF Score
Kissei Pharmaceutical Co Ltd KSPHF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Kissei Pharmaceutical Co (KSPHF) has a Moat Score of 5 as of Aug. 04, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #55 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is Kissei Pharmaceutical Co's Moat Score too high?
Kissei Pharmaceutical Co's current Moat Score is 5. Based on the distribution chart, Kissei Pharmaceutical Co ranks #55 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Moat Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #55 out of 1029 companies for Moat Score. This places Kissei Pharmaceutical Co in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Kissei Pharmaceutical Co's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Kissei Pharmaceutical Co (KSPHF) has a current Moat Score of 5. The stock's GF Value™ is $31.34, compared to a current price of $25.77 — trading 17.8% below its estimated fair value. The current Moat Score is 5. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Kissei Pharmaceutical Co (KSPHF), the current Moat Score is 5 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kissei Pharmaceutical Co (KSPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of $25.77 is trading 17.8% below its estimated GF Value™ of $31.34.

Key valuation signals for KSPHF:

  • Moat Score: 5
  • GF Value™: $31.34 vs. price of $25.77 (17.8% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the KSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kissei Pharmaceutical Co Business Description

Other Exchanges 4547:Japan
Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score

Get the complete analysis for KSPHF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.77
Price
$31.34
GF Value